Denosumab Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 60 mg/mL, 120 mg/1.7 mL

Reference Brands: Prolia, Xgeva

Category: Osteoporosis

Denosumab is available in Injection and strengths such as 60 mg/mL, 120 mg/1.7 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Denosumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Denosumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Denosumab is a leading RANKL-inhibiting monoclonal antibody used in the treatment of osteoporosis, cancer-related bone loss, and bone metastases. Available as a 60 mg/mL prefilled syringe (Prolia®) for biannual dosing and 120 mg/1.7 mL (Xgeva®) for monthly administration, Denosumab offers effective and long-acting bone protection. Trusted globally under Amgen's Prolia and Xgeva brands, it is approved across the US and EU. Denosumab is manufactured in GMP-certified facilities and is available for B2B pharmaceutical distribution, including hospitals and oncology clinics. Contact us for bulk export, COAs, and regulatory documentation.